Dimethyl Sulfoxide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01093 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 13 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Plasmodium falciparum malaria | KG + DL |
| 2 | peritonitis | KG + DL |
| 3 | Smouldering systemic mastocytosis | KG + DL |
| 4 | HIV infectious disease | KG + DL |
| 5 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 6 | systemic mastocytosis | KG + DL |
| 7 | appendicitis | KG + DL |
| 8 | meningococcal infection | KG + DL |
| 9 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 10 | feline acquired immunodeficiency syndrome | KG + DL |
| 11 | simian immunodeficiency virus infection | KG + DL |
| 12 | bacterial arthritis | KG + DL |
| 13 | pneumonia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.